Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in Refractory Brain Tumors
NCT00003457Phase 2Completed
- Sponsor
- Burzynski Research Institute
- Start
- Jul 1996
- Primary completion
- Feb 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in brain tumor, sponsored by Burzynski Research Institute. Started Jul 1996; status: completed.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT00003457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003457.